At-Home Testing Market Snapshot (2022 to 2032)

The global at-home testing market is expected to enjoy a valuation of US$ 7.1 billion in 2022, and further expand at a CAGR of 4.0% to reach a valuation of US$ 10.5 billion by the end of the year 2032. According to a recent study by Future Market Insights, digital monitoring system products are leading the market with a share of about 46.7% in the year 2021, within the global at-home testing market.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 7.1 billion
Market Value 2032 US$ 10.5 billion
CAGR 2022 to 2032 4.0%
Market Share of Top 5 Countries 55.5%
Key Market Players Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA., Everlywell, and LetsgetChecked.

The at-home testing market has gained popularity recently due to the numerous new alternatives it has provided for patients. They aid in the continuous monitoring of health issues, such as blood sugar and cholesterol levels, as well as the diagnosis and treatment of new patients who test positive for specific indications.

With at-home testing kits being well accepted in the market, manufacturers have seized the opportunity to offer novel kits for the well-being of patients suffering from chronic disorders, as well as in the management of several ailments.

One of the primary reasons for the market's predicted opportunistic expansion is the flexibility it affords to the self-testing audience. The rising usage of opioids and drug abuse testing has opened up new opportunities in the pain management area.

With so many brands of at-home testing kits available in the market, the FDA has set up certain regulations, including a warning about not using pre-used test strips, on 21 June 2022. It has also set up a website enlisting all the approved home tests.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of At-Home Testing Market from 2015 to 2021 Vs Market Outlook for 2022 to 2032

The market value for at-home testing products was approximately 5.8% of the overall ~US$ 118.5 billion of the global in-vitro diagnostics market in 2021.

The at-home testing industry has drawn a lot of attention since it offers a highly convenient way to conduct tests from the comfort of one's own home. Market players are taking advantage of this opportunity to expand their businesses and branch out into other areas

The at-home market is predicted to grow throughout the forecast period, because of the increase in business development tactics such as collaboration and acquisition by leading industry players.

For instance, Viatris Inc along with Atomo Diagnostics Limited collaborated with the globally renounced health agency Unit Aid, in the year of April 2021, to make HIV testing kits more accessible in developing countries.

Another promising reason for the lucrative growth of the market is the increasing popularity of self-testing kits among consumers . Pregnancy self-tests and blood glucose self-testing have gained so much popularity through extensive marketing that they have now become routine and useful for consumers.

To ensure the efficacy of norms, the entire regulatory landscape in the self-testing business is continually altering. In-vitro diagnostic medical devices (IVD) regulations for self-testing kits are in effect in the United States.

Owing to the aforementioned factors, the at-home testing market is expected to grow at a CAGR of 4.0% during the forecast period from 2022 to 2032.

At-Home Testing Market

What are the Key Opportunities for the At-Home Testing Product Manufacturers?

The market is set to present an opportunistic outlook, due to technological developments in sample collection and manufacturers' efforts to develop easy-to-use disposable test kits.

These test kits use sweat, semen, and even hair samples for giving test results, which sometimes the consumer is not comfortable giving in public. At-home testing kits have made this more accessible for consumers. People can be tested easily for fertility checks and even drug abuse.

The growth will further be propelled by the adoption of self-testing policies encouraging the use of self-diagnostic kits. Developed countries are enacting self-testing policies and developing self-testing guidelines.

According to the WHO, around 41 countries have implemented HIV self-testing policies. Many countries have similar policies in place for Hepatitis B and C.

With the implementation of such government laws, the general population is encouraged to utilize self-diagnostic kits, creating significant chances for the at-home testing market to flourish.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand for At-Home Testing Products?

Despite the fact that the at-home testing market includes multiple end-uses, certain challenges are expected to impede market expansion. The price increase for at-home testing kits will be a setback for this sector. Self-testing policies and recommendations are being developed in developed countries. As a result, the high pricing of testing kits will prevent the market from expanding.

Additionally, the projected expansion of the global at-home testing market is anticipated to be hampered by the rising number of product recalls of self-testing kits by regulatory bodies like the USA FDA. There are multiple pieces of evidence of such recalls in the market.

These variables in total propose an adverse consequence on the formative development of the at-home testing market.

Country-wise Insights

What Makes the USA a Highly Lucrative Market for At-home Testing Products?

The USA dominates the North American region with a total market share of about 91.6 % in 2021 and is expected to continue the same through the forecast period.

This is because the USA market is highly fragmented with many new market players trying to promote their products, launch multiple innovative products, high prevalence of certain chronic and infectious diseases, and high awareness among consumers. The USA Federal government has also introduced a lot of schemes and awareness programs for the higher adoption of self-test kits and to get tested.

The rate of obese people living in the USA is also high, and high diabetic awareness has increased the adoption of continuous blood glucose monitors.

What is the outlook of China for the At-Home Testing Market?

China is expected to display growth at a CAGR of 5.2% in the East Asia market over the forecast period.

The market for self-testing devices in China is increasing. Medical chemistry, immunoassay, coagulation, hematology, and microbiology are all highly sought-after fields. Another indicator of potential opportunities in China is the employment of in-house manufactured devices.

Because the country's economy is intricately linked to its healthcare system, the market is expected to grow in the future years. The Chinese government's expanding initiatives to promote the healthcare sector, which is another factor fuelling demand for self-testing kits.

What makes The United Kingdom a demanding market for At-Home Testing?

The United Kingdom holds the largest market share in Europe at-home testing market in 2021 generating revenue of close to US$ 386.2 million and is expected to grow with a CAGR of 2.2% during the forecasted period.

People's regular habit of visiting clinic have been replaced with the awareness of self-test kits in the market. Self-testing kits are readily accessible at pharmacies, and obtaining them has never been simpler. Numerous healthcare organizations are entering this market since they quickly produce self-test kits.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which At-Home Testing Product is driving the Market?

Digital monitoring systems held a market share of around 46.7% in the global market in 2021, and the segment is expected to grow with a CAGR of 4.4% during the forecast period.

The ability of sensors to record precise data for predicted, planned, and emergency maintenance adds cost efficiencies to digital monitoring. Furthermore, they are easy to use as they have stronger compliance as all the medical data is automatically stored in the system. Hence, they have a greater preference, and the market is set to expand as a result.

What Application of At-Home Testing Kit is Largely in Focus Globally?

Blood glucose testing has shown increased demand with a market share of 70.4% globally in 2021 and is expected to grow with a CAGR of 3.8% during the forecast period.

Blood glucose monitors are widely used for home tests as they provide a timely and dependable assessment of an individual's blood glucose concentrations in order to make appropriate food, exercise, and medication decisions. In addition, they are handy, can be used for a prolonged time, and help to keep sugar levels in check.

Which Sample is Largely Used for At-Home Self-Testing Kits?

Blood is widely used as a sample for at-home testing kits as it evaluates the overall health, checks the function of specific organs such as the liver and kidneys, and screens for genetic diseases. The segment holds the largest market share with revenue of nearly US$ 5.1 billion in the global market and is expected to grow with a CAGR of 3.8% in the forecast period.

Which Distribution Channel Benefits the Most from the Sales of At-Home Testing Products?

Drug stores hold the highest market share value of 49.6% during the year 2021 globally.

This is because most drug stores and local pharmacies have multiple options for home test kits. They are easily accessible, and consumers can select from a wide range of products. The presence of established drug store chains and supermarket chains like Walmart have even increased the adoption rate. Such chains are engaging in collaborations with at-home testing kit manufacturers to promote their products.

Competitive Landscape

The market is highly fragmented and there are many companies operating and launching new products in the market. Key Players such as Abbott Diagnostics, and Quest Direct (Quest Diagnostics), are adopting expansion of their business in the untapped markets and acquisition of smaller companies to promote their products.

In order to meet consumer demand and grow their customer base, other companies are also following their footsteps to do mergers and acquisitions, partnerships and collaborations, and new product launches.

The following are examples of key development strategies used by industry players in the at-home testing market:

  • Abbott Laboratories stated on June 3, 2022, that they would be developing a continuous glucose ketone-monitoring device that will allow people to keep track of their glucose ketone levels.
  • Morgan Health made a new investment in LetsGetChecked on September 8, 2022, to increase access to at-home healthcare solutions.

Similarly, recent developments related to companies manufacturing at-home testing products, have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Biodegradable Gloves Industry Analysis

Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2015 to 2021
Market Analysis US$ billion for Value, Units for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa.
Key Market Segments Covered Product, Application, Sample, Distribution Channel, and Region
Key Companies Profiled
  • Becton, Dickinson, and Company
  • Abbott
  • ACCESS BIO
  • CELLTRION INC.
  • Siemens Healthcare GmbH
  • ACON Laboratories Inc.
  • ARKRAY, Inc
  • F. Hoffmann-La Roche Ltd.
  • OraSure, Technologies Inc.,
  • Quest Diagnostics
  • Bionime Corporation
  • Btnx Inc.
  • iHealth Labs Inc.
  • InBios International, Inc. USA.
  • EverlyWell
  • LetsgetChecked.
Pricing Available upon Request

Key Market Segments Covered in At-Home Testing Industry Research

By Product:

  • Digital Monitoring Instruments
  • Cassettes
  • Midstream
  • Strips
  • Cups
  • Dip Cards
  • Test Panels
  • Sample collection kits
  • Others

By Application:

  • Blood Glucose Testing
  • Pregnancy & Fertility Testing
  • Cancer Testing
  • STD/ STI Testing
    • Chlamydia and Gonorrhoea
    • HIV Testing
  • Testosterone
  • Drug Abuse Testing
  • Cholesterol Testing
  • Thyroid Testing
  • Others

By Sample:

  • Urine
  • Blood
  • Saliva
  • Stool
  • Vaginal Swab
  • Semen

By Distribution Channel:

  • Drug Stores
  • Hospital Pharmacies
  • Online Channels

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much is the at-home testing market estimated worth in 2022?

The global at-home testing market is estimated to be worth US$ 7.1 billion in 2022 and is set to expand 1.5X over the next ten years.

What is the sales forecast for at-home testing market through 2032?

The at-home testing market is expected to reach US$ 10.5 billion by the end of 2032, with sales revenue expected to register 4.0% CAGR.

What are the key trends shaping the at-home testing market?

The expanding research and development of the at-home testing products, increased awareness about health and hygiene, HIV health awareness, immense advertising, and increasing number of infectious diseases, are the key trends being witnessed in this market.

Which are the top five countries driving demand for at-home testing?

The USA, Japan, China, The United Kingdom, and France are the top five countries and are expected to drive demand for the at-home testing kits market.

What is the North American market outlook for at-home testing?

North America is one of the key markets for at-home testing, with the USA accounting for around 91.6% of the North American at-home testing market in the year 2021.

At what percentage is the demand for at-home testing expected to register growth in Europe?

Demand for at-home testing in Europe is expected to register a growth of 4.1% CAGR over the next ten years.

Which countries are the key producers of at-home testing?

The USA, China, and the United Kingdom are the key producers of at-home testing products.

Who are the key players in the at-home testing market?

Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA, Everlywell, and LetsgetChecked, are the key players within the market.

How is the market in Japan shaping up?

The Japan market held a share of about 43.8% in the East Asia at-home testing market in 2021.

Which is the major product type segment in market?

Digital monitoring system is the major product segment in the global at-home testing market with a share of 46.7% in the year 2021.

Table of Content
1. Executive Summary | At-Home Testing Market
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation / Development Trends
4. Key Success Factors
    4.1. Product Adoption / Usage Analysis
    4.2. Product USPs / Features
    4.3. PESTLE Analysis
    4.4. Porter’s Analysis
    4.5. Regulatory Scenario
    4.6. Reimbursement Scenario
    4.7. Sample Collection Analysis, By Country
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Spending Outlook
        5.1.3. Global In-Vitro Diagnostics Market Overview
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Rising Awareness about Self Testing Kits
        5.2.2. Transition from Lab-based Screening to Disposable Devices
        5.2.3. Easy Availability & Government Recommendations
        5.2.4. Rising Per Capita Disposable Income
        5.2.5. Collaborations With e-Commerce Partners
        5.2.6. Increasing Adoption of Dual Capability Tests
        5.2.7. Regulatory Scenario
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
        6.1.1. By Product
        6.1.2. By Application
        6.1.3. By Sample
        6.1.4. By Distribution Channel
        6.1.5. By Region
    6.2. 2021 Market Scenario
7. Global Market Demand in Volume (Units) Analysis 2015 to 2021 and Forecast, 2022 to 2032
    7.1. Historical Market Volume (Units) Analysis, 2015 to 2021
    7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
        7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
    8.1. Regional Pricing Analysis by Product
    8.2. Pricing Break Up
        8.2.1. Manufacturer Level
        8.2.2. Distributor Level
    8.3. Global Average Pricing Analysis Benchmark
    8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ million) Analysis 2015 to 2021 and Forecast, 2022 to 2032
    9.1. Historical Market Value (US$ million) Analysis 2015 to 2021
    9.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
        9.2.1. Y-o-Y Growth Trend Analysis
        9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis, By Product
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ million) Analysis by Product, 2015 to 2021
    10.3. Current and Future Market Size (US$ million) Analysis and Forecast by Product, 2022 to 2032
        10.3.1. Digital Monitoring Instruments
        10.3.2. Cassettes
        10.3.3. Midstreams
        10.3.4. Strips
        10.3.5. Cups
        10.3.6. Dip Cards
        10.3.7. Test Panels
        10.3.8. Sample collection kits
        10.3.9. Others
    10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis, By Application
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Application, 2015 to 2021
    11.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Application, 2022 to 2032
        11.3.1. Blood Glucose Testing
        11.3.2. Pregnancy & Fertility Testing
        11.3.3. Cancer Testing
        11.3.4. Search and Rescue
        11.3.5. STD/ STI Testing
            11.3.5.1. Chlamydia and Gonorrhea
            11.3.5.2. HIV Testing
        11.3.6. Cholesterol Testing
        11.3.7. Testosterone
        11.3.8. Drug of Abuse Testing
        11.3.9. Cholesterol Testing
        11.3.10. Thyroid Testing
        11.3.11. Others
    11.4. Market Attractiveness Analysis by Application
12. Global Market Analysis, By Sample
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ million) Analysis by Sample, 2015 to 2021
    12.3. Current and Future Market Size (US$ million) Analysis and Forecast by Sample, 2022 to 2032
        12.3.1. Urine
        12.3.2. Blood
        12.3.3. Saliva
        12.3.4. Stool
        12.3.5. Vaginal Swab
        12.3.6. Semen
    12.4. Market Attractiveness Analysis by Sample
13. Global Market Analysis, By Distribution Channel
    13.1. Introduction
    13.2. Historical Market Size (US$ million) Analysis by Distribution Channel, 2015 to 2021
    13.3. Current and Future Market Size (US$ million) Analysis and Forecast by Distribution Channel, 2022 to 2032
        13.3.1. Drug Stores
        13.3.2. Hospital Pharmacies
        13.3.3. Online Channels
    13.4. Market Attractiveness Analysis by Distribution Channel
14. Global Market Analysis, by Region
    14.1. Introduction
    14.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Region, 2015 to 2021
    14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032
        14.3.1. North America
        14.3.2. Latin America
        14.3.3. Europe
        14.3.4. South Asia
        14.3.5. East Asia
        14.3.6. Oceania
        14.3.7. Middle East & Africa
    14.4. Market Attractiveness Analysis By Region
15. North America Market Analysis
    15.1. Introduction
    15.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        15.3.1. By Country
            15.3.1.1. The USA
            15.3.1.2. Canada
        15.3.2. By Product
        15.3.3. By Application
        15.3.4. By Sample
        15.3.5. By Distribution Channel
    15.4. Market Attractiveness Analysis
        15.4.1. By Product
        15.4.2. By Application
        15.4.3. By Sample
        15.4.4. By Distribution Channel
    15.5. Market Trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country-Level Analysis & Forecast
        15.8.1. The USA Market Analysis
            15.8.1.1. Introduction
            15.8.1.2. Market Analysis and Forecast by Market Taxonomy
                15.8.1.2.1. By Product
                15.8.1.2.2. By Application
                15.8.1.2.3. By Sample
                15.8.1.2.4. By Distribution Channel
        15.8.2. Canada Market Analysis
            15.8.2.1. Introduction
            15.8.2.2. Market Analysis and Forecast by Market Taxonomy
                15.8.2.2.1. By Product
                15.8.2.2.2. By Application
                15.8.2.2.3. By Sample
                15.8.2.2.4. By Distribution Channel
16. Latin America Market Analysis
    16.1. Introduction
    16.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        16.3.1. By Country
            16.3.1.1. Brazil
            16.3.1.2. Mexico
            16.3.1.3. Argentina
            16.3.1.4. Rest of Latin America
        16.3.2. By Product
        16.3.3. By Application
        16.3.4. By Sample
        16.3.5. By Distribution Channel
    16.4. Market Attractiveness Analysis
        16.4.1. By Product
        16.4.2. By Application
        16.4.3. By Sample
        16.4.4. By Distribution Channel
    16.5. Market Trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country-Level Analysis & Forecast
        16.8.1. Brazil Market Analysis
            16.8.1.1. Introduction
            16.8.1.2. Market Analysis and Forecast by Market Taxonomy
                16.8.1.2.1. By Product
                16.8.1.2.2. By Application
                16.8.1.2.3. By Sample
                16.8.1.2.4. By Distribution Channel
        16.8.2. Mexico Market Analysis
            16.8.2.1. Introduction
            16.8.2.2. Market Analysis and Forecast by Market Taxonomy
                16.8.2.2.1. By Product
                16.8.2.2.2. By Application
                16.8.2.2.3. By Sample
                16.8.2.2.4. By Distribution Channel
        16.8.3. Argentina Market Analysis
            16.8.3.1. Introduction
            16.8.3.2. Market Analysis and Forecast by Market Taxonomy
                16.8.3.2.1. By Product
                16.8.3.2.2. By Application
                16.8.3.2.3. By Sample
                16.8.3.2.4. By Distribution Channel
17. Europe Market Analysis
    17.1. Introduction
    17.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        17.3.1. By Country
            17.3.1.1. Germany
            17.3.1.2. Italy
            17.3.1.3. France
            17.3.1.4. The United Kingdom
            17.3.1.5. Spain
            17.3.1.6. BENELUX
            17.3.1.7. Russia
            17.3.1.8. Rest of Europe
        17.3.2. By Product
        17.3.3. By Application
        17.3.4. By Sample
        17.3.5. By Distribution Channel
    17.4. Market Attractiveness Analysis
        17.4.1. By Product
        17.4.2. By Application
        17.4.3. By Sample
        17.4.4. By Distribution Channel
    17.5. Market Trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country-Level Analysis & Forecast
        17.8.1. Germany Market Analysis
            17.8.1.1. Introduction
            17.8.1.2. Market Analysis and Forecast by Market Taxonomy
                17.8.1.2.1. By Product
                17.8.1.2.2. By Application
                17.8.1.2.3. By Sample
                17.8.1.2.4. By Distribution Channel
        17.8.2. Italy Market Analysis
            17.8.2.1. Introduction
            17.8.2.2. Market Analysis and Forecast by Market Taxonomy
                17.8.2.2.1. By Product
                17.8.2.2.2. By Application
                17.8.2.2.3. By Sample
                17.8.2.2.4. By Distribution Channel
        17.8.3. France Market Analysis
            17.8.3.1. Introduction
            17.8.3.2. Market Analysis and Forecast by Market Taxonomy
                17.8.3.2.1. By Product
                17.8.3.2.2. By Application
                17.8.3.2.3. By Sample
                17.8.3.2.4. By Distribution Channel
        17.8.4. The United Kingdom Market Analysis
            17.8.4.1. Introduction
            17.8.4.2. Market Analysis and Forecast by Market Taxonomy
                17.8.4.2.1. By Product
                17.8.4.2.2. By Application
                17.8.4.2.3. By Sample
                17.8.4.2.4. By Distribution Channel
        17.8.5. Spain Market Analysis
            17.8.5.1. Introduction
            17.8.5.2. Market Analysis and Forecast by Market Taxonomy
                17.8.5.2.1. By Product
                17.8.5.2.2. By Application
                17.8.5.2.3. By Sample
                17.8.5.2.4. By Distribution Channel
        17.8.6. BENELUX Market Analysis
            17.8.6.1. Introduction
            17.8.6.2. Market Analysis and Forecast by Market Taxonomy
                17.8.6.2.1. By Product
                17.8.6.2.2. By Application
                17.8.6.2.3. By Sample
                17.8.6.2.4. By Distribution Channel
        17.8.7. Russia Market Analysis
            17.8.7.1. Introduction
            17.8.7.2. Market Analysis and Forecast by Market Taxonomy
                17.8.7.2.1. By Product
                17.8.7.2.2. By Application
                17.8.7.2.3. By Sample
                17.8.7.2.4. By Distribution Channel
18. South Asia Market Analysis
    18.1. Introduction
    18.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        18.3.1. By Country
            18.3.1.1. India
            18.3.1.2. Indonesia
            18.3.1.3. Malaysia
            18.3.1.4. Thailand
            18.3.1.5. Vietnam
            18.3.1.6. Philippines
            18.3.1.7. Rest of South Asia
        18.3.2. By Product
        18.3.3. By Application
        18.3.4. By Sample
        18.3.5. By Distribution Channel
    18.4. Market Attractiveness Analysis
        18.4.1. By Product
        18.4.2. By Application
        18.4.3. By Sample
        18.4.4. By Distribution Channel
    18.5. Market Trends
    18.6. Key Market Participants - Intensity Mapping
    18.7. Drivers and Restraints - Impact Analysis
    18.8. Country-Level Analysis & Forecast
        18.8.1. India Market Analysis
            18.8.1.1. Introduction
            18.8.1.2. Market Analysis and Forecast by Market Taxonomy
                18.8.1.2.1. By Product
                18.8.1.2.2. By Application
                18.8.1.2.3. By Sample
                18.8.1.2.4. By Distribution Channel
        18.8.2. Indonesia Market Analysis
            18.8.2.1. Introduction
            18.8.2.2. Market Analysis and Forecast by Market Taxonomy
                18.8.2.2.1. By Product
                18.8.2.2.2. By Application
                18.8.2.2.3. By Sample
                18.8.2.2.4. By Distribution Channel
        18.8.3. Malaysia Market Analysis
            18.8.3.1. Introduction
            18.8.3.2. Market Analysis and Forecast by Market Taxonomy
                18.8.3.2.1. By Product
                18.8.3.2.2. By Application
                18.8.3.2.3. By Sample
                18.8.3.2.4. By Distribution Channel
        18.8.4. Thailand Market Analysis
            18.8.4.1. Introduction
            18.8.4.2. Market Analysis and Forecast by Market Taxonomy
                18.8.4.2.1. By Product
                18.8.4.2.2. By Application
                18.8.4.2.3. By Sample
                18.8.4.2.4. By Distribution Channel
        18.8.5. Vietnam Market Analysis
            18.8.5.1. Introduction
            18.8.5.2. Market Analysis and Forecast by Market Taxonomy
                18.8.5.2.1. By Product
                18.8.5.2.2. By Application
                18.8.5.2.3. By Sample
                18.8.5.2.4. By Distribution Channel
        18.8.6. Philippines Market Analysis 
            18.8.6.1. Introduction
            18.8.6.2. Market Analysis and Forecast by Market Taxonomy
                18.8.6.2.1. By Product
                18.8.6.2.2. By Application
                18.8.6.2.3. By Sample
                18.8.6.2.4. By Distribution Channel
19. East Asia Market Analysis
    19.1. Introduction
    19.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        19.3.1. By Country
            19.3.1.1. China
            19.3.1.2. Japan
            19.3.1.3. South Korea
        19.3.2. By Product
        19.3.3. By Application
        19.3.4. By Sample
        19.3.5. By Distribution Channel
    19.4. Market Attractiveness Analysis
        19.4.1. By Product
        19.4.2. By Application
        19.4.3. By Sample
        19.4.4. By Distribution Channel
    19.5. Market Trends
    19.6. Key Market Participants - Intensity Mapping
    19.7. Drivers and Restraints - Impact Analysis
    19.8. Country-Level Analysis & Forecast
        19.8.1. China Market Analysis
            19.8.1.1. Introduction
            19.8.1.2. Market Analysis and Forecast by Market Taxonomy
                19.8.1.2.1. By Product
                19.8.1.2.2. By Application
                19.8.1.2.3. By Sample
                19.8.1.2.4. By Distribution Channel
        19.8.2. Japan Market Analysis
            19.8.2.1. Introduction
            19.8.2.2. Market Analysis and Forecast by Market Taxonomy
                19.8.2.2.1. By Product
                19.8.2.2.2. By Application
                19.8.2.2.3. By Sample
                19.8.2.2.4. By Distribution Channel
        19.8.3. South Korea Market Analysis
            19.8.3.1. Introduction
            19.8.3.2. Market Analysis and Forecast by Market Taxonomy
                19.8.3.2.1. By Product
                19.8.3.2.2. By Application
                19.8.3.2.3. By Sample
                19.8.3.2.4. By Distribution Channel
20. Oceania Market Analysis
    20.1. Introduction
    20.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    20.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        20.3.1. By Country
            20.3.1.1. Australia
            20.3.1.2. New Zealand
        20.3.2. By Product
        20.3.3. By Application
        20.3.4. By Sample
        20.3.5. By Distribution Channel
    20.4. Market Attractiveness Analysis
        20.4.1. By Product
        20.4.2. By Application
        20.4.3. By Sample
        20.4.4. By Distribution Channel
    20.5. Market Trends
    20.6. Key Market Participants - Intensity Mapping
    20.7. Drivers and Restraints - Impact Analysis
    20.8. Country-Level Analysis & Forecast
        20.8.1. Australia Market Analysis
            20.8.1.1. Introduction
            20.8.1.2. Market Analysis and Forecast by Market Taxonomy
                20.8.1.2.1. By Product
                20.8.1.2.2. By Application
                20.8.1.2.3. By Sample
                20.8.1.2.4. By Distribution Channel
        20.8.2. New Zealand Market Analysis
            20.8.2.1. Introduction
            20.8.2.2. Market Analysis and Forecast by Market Taxonomy
                20.8.2.2.1. By Product
                20.8.2.2.2. By Application
                20.8.2.2.3. By Sample
                20.8.2.2.4. By Distribution Channel
21. Middle East and Africa Market Analysis
    21.1. Introduction
    21.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Market Taxonomy, 2015 to 2021
    21.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        21.3.1. By Country
            21.3.1.1. GCC Countries
            21.3.1.2. Turkey
            21.3.1.3. North Africa
            21.3.1.4. South Africa
            21.3.1.5. Rest of Middle East and Africa
        21.3.2. By Product
        21.3.3. By Application
        21.3.4. By Sample
        21.3.5. By Distribution Channel
    21.4. Market Attractiveness Analysis
        21.4.1. By Product
        21.4.2. By Application
        21.4.3. By Sample
        21.4.4. By Distribution Channel
    21.5. Market Trends
    21.6. Key Market Participants - Intensity Mapping
    21.7. Drivers and Restraints - Impact Analysis
    21.8. Country-Level Analysis & Forecast
        21.8.1. GCC Countries Market Analysis
            21.8.1.1. Introduction
            21.8.1.2. Market Analysis and Forecast by Market Taxonomy
                21.8.1.2.1. By Product
                21.8.1.2.2. By Application
                21.8.1.2.3. By Sample
                21.8.1.2.4. By Distribution Channel
        21.8.2. Turkey Market Analysis
            21.8.2.1. Introduction
            21.8.2.2. Market Analysis and Forecast by Market Taxonomy
                21.8.2.2.1. By Product
                21.8.2.2.2. By Application
                21.8.2.2.3. By Sample
                21.8.2.2.4. By Distribution Channel
        21.8.3. North Africa Market Analysis
            21.8.3.1. Introduction
            21.8.3.2. Market Analysis and Forecast by Market Taxonomy
                21.8.3.2.1. By Product
                21.8.3.2.2. By Application
                21.8.3.2.3. By Sample
                21.8.3.2.4. By Distribution Channel
        21.8.4. South Africa Market Analysis
            21.8.4.1. Introduction
            21.8.4.2. Market Analysis and Forecast by Market Taxonomy
                21.8.4.2.1. By Product
                21.8.4.2.2. By Application
                21.8.4.2.3. By Sample
                21.8.4.2.4. By Distribution Channel
22. Market Structure Analysis
    22.1. Market Analysis by Tier of Companies
    22.2. Market Share Analysis of Top Players
    22.3. Market Presence Analysis
        22.3.1. Regional Footprint by Players
        22.3.2. Product Footprint by Players
        22.3.3. Channel Foot Print by Players
23. Competition Analysis
    23.1. Competition Dashboard
    23.2. Competition Benchmarking
    23.3. Competition Deep Dive
        23.3.1. Abbott
            23.3.1.1. Overview
            23.3.1.2. Product Portfolio
            23.3.1.3. Sales Footprint
            23.3.1.4. Key Financials
            23.3.1.5. SWOT Analysis
            23.3.1.6. Strategy Overview
                23.3.1.6.1. Marketing Strategy
                23.3.1.6.2. Product strategy
                23.3.1.6.3. Channel Strategy
        23.3.2. Becton, Dickinson and Company.
            23.3.2.1. Overview
            23.3.2.2. Product Portfolio
            23.3.2.3. Sales Footprint
            23.3.2.4. Key Financials
            23.3.2.5. SWOT Analysis
            23.3.2.6. Strategy Overview
                23.3.2.6.1. Marketing Strategy
                23.3.2.6.2. Product strategy
                23.3.2.6.3. Channel Strategy
        23.3.3. ACCESS BIO
            23.3.3.1. Overview
            23.3.3.2. Product Portfolio
            23.3.3.3. Sales Footprint
            23.3.3.4. Key Financials
            23.3.3.5. SWOT Analysis
            23.3.3.6. Strategy Overview
                23.3.3.6.1. Marketing Strategy
                23.3.3.6.2. Product strategy
                23.3.3.6.3. Channel Strategy
        23.3.4. CELLTRION INC.
            23.3.4.1. Overview
            23.3.4.2. Product Portfolio
            23.3.4.3. Sales Footprint
            23.3.4.4. Key Financials
            23.3.4.5. SWOT Analysis
            23.3.4.6. Strategy Overview
                23.3.4.6.1. Marketing Strategy
                23.3.4.6.2. Product strategy
                23.3.4.6.3. Channel Strategy
        23.3.5. Siemens Healthcare GmbH
            23.3.5.1. Overview
            23.3.5.2. Product Portfolio
            23.3.5.3. Sales Footprint
            23.3.5.4. Key Financials
            23.3.5.5. SWOT Analysis
            23.3.5.6. Strategy Overview
                23.3.5.6.1. Marketing Strategy
                23.3.5.6.2. Product strategy
                23.3.5.6.3. Channel Strategy
        23.3.6. ACON Laboratories Inc.
            23.3.6.1. Overview
            23.3.6.2. Product Portfolio
            23.3.6.3. Sales Footprint
            23.3.6.4. Key Financials
            23.3.6.5. SWOT Analysis
            23.3.6.6. Strategy Overview
                23.3.6.6.1. Marketing Strategy
                23.3.6.6.2. Product Strategy
                23.3.6.6.3. Channel Strategy
        23.3.7. ARKRAY, Inc
            23.3.7.1. Overview
            23.3.7.2. Product Portfolio
            23.3.7.3. Sales Footprint
            23.3.7.4. Key Financials
            23.3.7.5. SWOT Analysis
            23.3.7.6. Strategy Overview
                23.3.7.6.1. Marketing Strategy
                23.3.7.6.2. Product Strategy
                23.3.7.6.3. Channel Strategy
        23.3.8. F. Hoffmann-La Roche Ltd.
            23.3.8.1. Overview
            23.3.8.2. Product Portfolio
            23.3.8.3. Sales Footprint
            23.3.8.4. Key Financials
            23.3.8.5. SWOT Analysis
            23.3.8.6. Strategy Overview
                23.3.8.6.1. Marketing Strategy
                23.3.8.6.2. Product strategy
                23.3.8.6.3. Channel Strategy
        23.3.9. OraSure, Technologies Inc.
            23.3.9.1. Overview
            23.3.9.2. Product Portfolio
            23.3.9.3. Sales Footprint
            23.3.9.4. Key Financials
            23.3.9.5. SWOT Analysis
            23.3.9.6. Strategy Overview
                23.3.9.6.1. Marketing Strategy
                23.3.9.6.2. Product strategy
                23.3.9.6.3. Channel Strategy
        23.3.10. Quest Diagnostics
            23.3.10.1. Overview
            23.3.10.2. Product Portfolio
            23.3.10.3. Sales Footprint
            23.3.10.4. Key Financials
            23.3.10.5. SWOT Analysis
            23.3.10.6. Strategy Overview
                23.3.10.6.1. Marketing Strategy
                23.3.10.6.2. Product strategy
                23.3.10.6.3. Channel Strategy
        23.3.11. Bionime Corporation
            23.3.11.1. Overview
            23.3.11.2. Product Portfolio
            23.3.11.3. Sales Footprint
            23.3.11.4. Key Financials
            23.3.11.5. SWOT Analysis
            23.3.11.6. Strategy Overview
                23.3.11.6.1. Marketing Strategy
                23.3.11.6.2. Product strategy
                23.3.11.6.3. Channel Strategy
        23.3.12. Btnx Inc.
            23.3.12.1. Overview
            23.3.12.2. Product Portfolio
            23.3.12.3. Sales Footprint
            23.3.12.4. Key Financials
            23.3.12.5. SWOT Analysis
            23.3.12.6. Strategy Overview
                23.3.12.6.1. Marketing Strategy
                23.3.12.6.2. Product strategy
                23.3.12.6.3. Channel Strategy
        23.3.13. iHealth Labs Inc.
            23.3.13.1. Overview
            23.3.13.2. Product Portfolio
            23.3.13.3. Sales Footprint
            23.3.13.4. Key Financials
            23.3.13.5. SWOT Analysis
            23.3.13.6. Strategy Overview
                23.3.13.6.1. Marketing Strategy
                23.3.13.6.2. Product strategy
                23.3.13.6.3. Channel Strategy
        23.3.14. InBios International, Inc. USA.
            23.3.14.1. Overview
            23.3.14.2. Product Portfolio
            23.3.14.3. Sales Footprint
            23.3.14.4. Key Financials
            23.3.14.5. SWOT Analysis
            23.3.14.6. Strategy Overview
                23.3.14.6.1. Marketing Strategy
                23.3.14.6.2. Product strategy
                23.3.14.6.3. Channel Strategy
        23.3.15. Everlywell
            23.3.15.1. Overview
            23.3.15.2. Product Portfolio
            23.3.15.3. Sales Footprint
            23.3.15.4. Key Financials
            23.3.15.5. SWOT Analysis
            23.3.15.6. Strategy Overview
                23.3.15.6.1. Marketing Strategy
                23.3.15.6.2. Product strategy
                23.3.15.6.3. Channel Strategy
        23.3.16. LetsgetChecked
            23.3.16.1. Overview
            23.3.16.2. Product Portfolio
            23.3.16.3. Sales Footprint
            23.3.16.4. Key Financials
            23.3.16.5. SWOT Analysis
            23.3.16.6. Strategy Overview
                23.3.16.6.1. Marketing Strategy
                23.3.16.6.2. Product strategy
                23.3.16.6.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Recommendations

Healthcare

Fertility and Pregnancy Rapid Test Kit Market

October 2023

REP-GB-607

183 pages

Healthcare

Continuous Glucose Monitoring Systems Market

September 2023

REP-GB-694

333 pages

Healthcare

Drug of Abuse Testing Market

June 2023

REP-GB-1649

306 pages

Healthcare

United States of America Digital Pregnancy Test Kits Market

June 2023

REP-GB-6108

342 pages

Explore Healthcare Insights

View Reports
Future Market Insights

At-Home Testing Market

Schedule a Call